BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11811361)

  • 1. Synergistic interaction of integrin and angiotensin II in activation of extracellular signal-regulated kinase pathways in vascular smooth muscle cells.
    Tamura K; Okazaki M; Tamura M; Kanegae K; Okuda H; Abe H; Nakashima Y
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S59-62. PubMed ID: 11811361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation.
    Blaschke F; Stawowy P; Kappert K; Goetze S; Kintscher U; Wollert-Wulf B; Fleck E; Graf K
    Basic Res Cardiol; 2002 Jul; 97(4):334-42. PubMed ID: 12111044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling.
    Tamura K; Okazaki M; Tamura M; Isozumi K; Tasaki H; Nakashima Y
    Life Sci; 2003 Jan; 72(9):1049-60. PubMed ID: 12495783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D; Schmitz U; Kramer HJ
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells.
    Taniyama Y; Ushio-Fukai M; Hitomi H; Rocic P; Kingsley MJ; Pfahnl C; Weber DS; Alexander RW; Griendling KK
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C494-9. PubMed ID: 15084475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
    Watts SW; Florian JA; Monroe KM
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells.
    Bunni MA; Kramarenko II; Walker L; Raymond JR; Garnovskaya MN
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C647-56. PubMed ID: 21148411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells.
    Govindarajan G; Eble DM; Lucchesi PA; Samarel AM
    Circ Res; 2000 Oct; 87(8):710-6. PubMed ID: 11029408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells.
    Lu G; Meier KE; Jaffa AA; Rosenzweig SA; Egan BM
    Hypertension; 1998 Apr; 31(4):978-85. PubMed ID: 9535424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK 1/2-dependent pathway.
    Liu G; Hitomi H; Rahman A; Nakano D; Mori H; Masaki T; Ma H; Iwamoto T; Kobori H; Nishiyama A
    Hypertens Res; 2014 Jan; 37(1):13-8. PubMed ID: 24026042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells.
    Laplante MA; Wu R; El Midaoui A; de Champlain J
    J Hypertens; 2003 May; 21(5):927-36. PubMed ID: 12714867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II and PDGF-BB stimulate beta(1)-integrin-mediated adhesion and spreading in human VSMCs.
    Kappert K; Schmidt G; Doerr G; Wollert-Wulf B; Fleck E; Graf K
    Hypertension; 2000 Jan; 35(1 Pt 2):255-61. PubMed ID: 10642307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1, but not Ang II, activates MAP kinases through c-Src independent Ras-Raf dependent pathways in vascular smooth muscle cells.
    Yogi A; Callera GE; Montezano AC; Aranha AB; Tostes RC; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1960-7. PubMed ID: 17569879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells.
    Velarde V; Jenkins AJ; Christopher J; Lyons TJ; Jaffa AA
    J Appl Physiol (1985); 2001 Sep; 91(3):1412-20. PubMed ID: 11509543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
    Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
    Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor.
    Li RC; Cindrova-Davies T; Skepper JN; Sellers LA
    Circ Res; 2004 Apr; 94(6):759-67. PubMed ID: 14963006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of monocyte chemoattractant protein-1 by integrins and platelet-derived growth factor via focal adhesion kinase in mesangial cells.
    Kanegae K; Tamura M; Kabashima N; Serino R; Tokunaga M; Oikawa S; Nakashima Y
    Nephrol Dial Transplant; 2005 Oct; 20(10):2080-8. PubMed ID: 16030037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells.
    Ishida M; Ishida T; Thomas SM; Berk BC
    Circ Res; 1998 Jan 9-23; 82(1):7-12. PubMed ID: 9440699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells.
    Goetze S; Xi XP; Graf K; Fleck E; Hsueh WA; Law RE
    FEBS Lett; 1999 Jun; 452(3):277-82. PubMed ID: 10386606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.